Τόμος 21 (2007) – Τεύχος 1 – Άρθρο 3 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 21 (2007) – Issue 1 – Article 3 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title Cytotoxic drugs (AII-Trans-R-A and hydroxyurea) on caspase-3 activity in pregnant rat (liver and kidney)
Authors H. Frangou¹, S. Massouridou¹, E.-N. Emmanouil² and M. Nikoloussis² 

1.      Department of General Biology, Faculty of Medicine, Aristotle University, Thessaloniki, Greece

2.     Department of Histology, Embryology and Anthropology, Faculty of Medicine, Aristotle University, Thessaloniki, Greece

Citation Frangou, H., Massouridou, S., Emmanouil, E.-N., Nikoloussis, M.: Cytotoxic drugs (AII-Trans-R-A and hydroxyurea) on caspase-3 activity in pregnant rat (liver and kidney), Epitheorese Klin. Farmakol. Farmakokinet. 21(1): : 24-30 (2007)
Publication Date Accepted for publication (Final version): 15 January 2007
Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €)

pharmakonpress[at]pharmakonpress[.]gr

Keywords Cytotoxic drugs, caspase-3 activity, pregnant rat.
Other Terms review article
Summary Hydroxyurea (HU) is a drug that causes birth defects in a variety of animals. Its pharmacologic actions include rapid killing of proliferating cells and profound inhibition of the synthesis of DNA. All-Trans-R-A is a Retinoid acid, natural derivative of vitamin A, which affect biological processes such as development, cell growth, and differentiation. AII-Trans-R-A as well as HU induces apoptosis in some cell types and tissues. Caspases belongs to a family of aspartate-specific cysteine proteases. Caspase-3 is an active caspase, effector, which degrades intracellular substrates. In healthy cells, caspases normally lie dormant. In response to diverse stimuli they become activated when cell death is required. The late stages of apoptotic process typically involve cleavage of specific target protein like lamin, actin or poly(ADP-ribose)polymerase. To further understand the apoptotic molecular mechanisms of AII-Trans-R-A and HU on rat liver and kidneys, caspase-3 activity was tested by colorimetric assay on subcellular fractions. Pregnant rats (230-260 g) were treated on Gestational days (GD), 9th, 10th with: a) corn oil, b) AII-Trans-R-A 50 mg/k.b. weight, c) NaCl 9=, d) HU 4.56 mg/k.b. weight. The animals were sacrificed at 17th day of pregnancy. The subcellular fractions were taken according to the method of Nordlie and Lardy, and the caspase-3 activity was determined by a colorimetric assay (kit, Sigma) based on the hydrolysis of the peptide substrate acetyl-Asp-Glu-Val-Asp p-nitroanilide (Ac-DEVD-pNA) by caspase-3, resulting the release of the p-nitroaniline (pNA) moiety. According to our results the caspase-3 activity was observed increased only in renal nuclear fraction after HU admmistration. There was no found any statistically difference with AH-Trans-R-A. In pregnant rat liver the caspase-3 activity was decreased after treatment with the above drugs in crude as well as in subcellular fractions. Our findings suggest that: a) HU may induce apoptosis in pregnant rat kidney cells via caspase-3 process, and b) All-Trans-R-A may produce downregulation of this process.
References 1.    Schwab M.: Encyclopedic Reference of Cancer. Pp. 73-77, Springer, Berlin, 2001

2.    Katzung B.C.: Basic and Clinical Pharmacology. 6rd ed., pp. 842-843), Appleton & Lange, California, 1995

3.    Lai L., Bohnsack B.L., Niederreither K., Hirschi K.K.: Retinoic acid regulates endothelial cell proliferation during vasculogenesis. Development 130: 6465-6474 (2003)

4.    De Luca L.M.: Retinoids and their receptors in differentiation, embryogenesis and neoplasia. FASEB J. 14: 2924¬2933 (1991)

5.    Emmanouil-Nikoloussi E.-N., Frangou-Massourides-H., Nikoloussis E., Massouridou S., Szabova E., Zeljenkova D., Navarova J.: Apoptotic effect of 13-Cis retinoic acid and Hydroxyurea on caspase-3 activity in mice placenta: an early marker of congenital malformations. Slov. Anthropol. 8(1): 129-132 (2005)

6.    Nordlie R.C., Lardy H.A.: Subcellular distribution of rat liver PPiase activity. Biochim. Biophys. Acta. 50: 189-191 (1961)

7.    Nickolson D.W., et all. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43 (1995)

8.    Sakahira H., Enari M., Nagata S.: Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391: 96-99 (1998)

9.    Thornberry N.A., Lazebnik Y.: Caspases: enemies within. Sciences 281: 1312-1316 (1998)

10.  Frangou H., Emmanouil-Nicolousi E., Nicolousis E., Likartsis X., Massouridou S.: The effect of teratogenic substances in caspase-3 activity of pregnant mice liver (Balb/c). Helliniki Iatriki 71: 221-226 (2005)

11.  Fitzgerald M.J., Webber E.M., Donovan J.R., Fausto N.: Rapid DNA binding by nuclear factor kappa B in hepetocytes at the start of liver regeneration. Cel Growth Differ. 6: 417-427 (1995)

12.  Radominska-Pandya A., Chen G., Czernik P.J., Little J.M., Samokyszyn V.M., Carter C.A., Nowak G.: Direct interaction of all-trans-retinoic acid with protein kinase C (PKC). J. Biol. Chem. 275: 22324-22330 (2000)

13.  Miliaras D., Emmanouil-Nikoloussi E.-N.: Molecular mechanisms controlling cell apoptosis. Greek Medical Annals 67(5-6): 8-17 (2001)

14.  Emmanouil-Nikoloussi E.-N., Frangou-Massourides H.: Teratogenic drugs and caspase-3 activity: the correlation of apoptotic effects in congenital malformations. Off. J. Eur. Teratol. Soc. Reprod. Toxicol. 20: 461 (2005)

15.  Emmanouil-Nikoloussi E.-N., Goret-Nicaise M., Foroglou P., Kerameos-Foroglou Ch., Persaud T.V.N., Thliveris J.A., Dhem A.: Histological observation of palatal malformations in rat embryos induced by retinoic acid treatment. Exp. Toxic. Pathol. 52: 437-444 (2000)

16.  DeSesso J.M.: Cell death and free radicals: a mechanism for hydroxyurea teratogenesis. Med. Hypotheses 5: 937-951 (1979)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2007 – ANNUAL SUBSCRIPTION 2007
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

 

Bookmark the permalink.

Comments are closed.